Hassenbusch, Samuel J <br/><br/>
Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial.  [electronic resource] 

 -  Neoplasia (New York, N.Y.)   
 - 9-16 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-8002 
<br/><br/><label>Standard No.: </label>10.1016/s1476-5586(03)80012-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Brain Neoplasms--drug therapy<br/>Carmustine--administration & dosage<br/>Ethanol<br/>Female<br/>Glioma--drug therapy<br/>Humans<br/>Injections, Intralesional<br/>Magnetic Resonance Imaging<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Stereotaxic Techniques<br/>Survival Rate